Table 3.
Level of certainty | Description |
High | The available evidence usually includes consistent results from well-designed, well-conducted studies in representative populations with suspected cervicogenic headache and/or facetogenic pain and/or compelling evidence from non-randomized studies. The studies assess the effects of the treatment, test, or other intervention on treatment or other relevant outcomes. The conclusion is therefore unlikely to be strongly affected by the results of future studies |
Moderate | The available evidence is sufficient to determine the
effects of the intervention on outcomes, but confidence in the estimate is
constrained by such factors as:
As more information becomes available, the magnitude or direction of the observed effect could change, and that change may be large enough to alter the conclusion |
Low | The available evidence is insufficient to assess effects
on treatment and other outcomes of interest. Evidence is insufficient because
of:
More information may allow estimation of effects on treatment outcomes |
Note, the levels of certainty described in the definitions for the grading of evidence in table 2 refer solely to the magnitude of benefit attributed to the intervention, while the levels of certainty in table 3 consider the basis of evidence for the recommendation and the likelihood the recommendation will be affected by future studies. Whereas the two are related, the grading of evidence and rating of certainty were considered separately.